Detalhe da pesquisa
1.
Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts.
PLoS Pathog
; 13(1): e1006108, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28081253
2.
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
J Infect Dis
; 213(11): 1743-51, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908756
3.
Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.
J Infect Dis
; 214(5): 772-81, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27307573
4.
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
J Infect Dis
; 211(7): 1076-86, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336730
5.
Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
Mol Ther
; 22(12): 2142-2154, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25156127
6.
Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
J Infect Dis
; 209(8): 1259-68, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24273174
7.
ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.
Mol Ther
; 20(12): 2355-68, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23089736
8.
A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.
J Infect Dis
; 205(7): 1035-42, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22396610
9.
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
J Infect Dis
; 205(5): 772-81, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22275401
10.
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Sci Transl Med
; 15(704): eadf1782, 2023 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437014
11.
Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
Mol Ther
; 19(12): 2269-76, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21862998
12.
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics.
Front Immunol
; 13: 984323, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36072606
13.
Impact of a blood-stage vaccine on Plasmodium vivax malaria.
medRxiv
; 2022 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664997
14.
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
Front Immunol
; 12: 694759, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34335606
15.
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Med
; 2(6): 701-719.e19, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223402
16.
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly.
JCI Insight
; 6(23)2021 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34609964
17.
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.
Sci Rep
; 8(1): 3390, 2018 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29467399
18.
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP.
NPJ Vaccines
; 3: 49, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323956
19.
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.
JCI Insight
; 2(12)2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28614791
20.
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.
JCI Insight
; 2(21)2017 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29093263